KNOW
YOUR MIND
Enabling precision medicine
for neurodegenerative
diseases
Our vision is to be the premier provider of information and technology to researchers and clinicians in order to improve brain health.
Our mission
To provide broad access to biomarkers of neurological pathologies, essential enabling tools to accelerate the development and approval of effective blood tests and therapies to diagnose and treat Lewy body dementia, Alzheimer’s disease, Parkinson’s disease, ALS and other neurodegenerative diseases.
NeuroDex is developing a suite of blood-based biomarkers that can identify patients with synucleinopathies even in the context of different forms of dementia.
This technology relies on NeuroDex’s recent advances in isolating cell-specific extracellular vesicles (exosomes) from plasma and detecting protein markers of disease in the contents or on the surface of NDEs.
Our tech
How we leverage cell-specific exosomes for diagnostics
Learn more
Collaboration
Collaborations with industry and academia. Want to work together?
Learn more
Our Partners
